Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer’s disease: a 6-month, randomized, placebo-controlled, multicenter trial

Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer’s disease: a 6-month, randomized, placebo-controlled, multicenter trial

Alan G Wade,1 Mildred Farmer,2 Gil Harari,3 Naama Fund,3 Moshe Laudon,4 Tali Nir,4 Anat Frydman-Marom,4 Nava Zisapel4,51CPS Research, Glasgow, UK; 2Meridien Research Inc., St Petersburg, FL, USA; 3Medistat, Ltd, 4Neurim Pharmaceuticals Ltd, Tel Aviv, Israel; 5Department of Neurobiology, Faculty of L...

Full description

Bibliographic Details
Main Authors: Wade AG, Farmer M, Harari G, Fund N, Laudon M, Nir T, Frydman-Marom A, Zisapel N
Format: Article
Language:English
Published: Dove Medical Press 2014-06-01
Series:Clinical Interventions in Aging
Subjects:
acetylcholinesterase inhibitors
memantine
insomnia
Online Access:https://www.dovepress.com/add-on-prolonged-release-melatonin-for-cognitive-function-and-sleep-in-peer-reviewed-article-CIA

Similar Items

Similar Items